Member Info for bewise

Go to clinical trials . Gov if you want a look at the trial which is very informative...:)

The published expected timetable for cf results have not changed from the company. No results were to be published last year from what i can see. Furthermore a company cannot with hold results from the market whether they are good or if they are bad. We will know the results as per the company timetable. I am quite optimistic about the results but if they fail to dazzle the cf is only a side show to the main player copd. I am extremley bullish here because of published facts/reaults, i disagree with others bearish stance as it is based on nothing factual :)

Everything looks good :) http://investors.veronapharma.com/static-files/49b6fe71-9d8d-4bbd-910c-2036f6ff8fcc

Nice steady upward movement of sp as we move forward towards results news....

Sentiment rising on expectation of results, hopefully game changing ones at that.:) Gla.

Up nearly 6% stateside, sentiment building :)

Phase 2 due to report mid 2018, hoping for impressive results and CF results first half of 2018. I am very happy with my investment here and hoping to see a uplift in sentiment and sp....

May 2018 bring a substantive increase in our share price. The only way is up from here :)

A good entry point as the sp trails the bottom imo also an encouraging broker note/ price target(on the conservative side imo) and not forgetting the chairman purchase....looking forward to 2018 and those test results:)

Still very upbeat, this share is prone to large sp swings as we have all seen over the years and in the last month or so. The rock bottom price at the mo will leave many pi's downcast but as we know the sp can reverse very quickly, buy low and sell high is the mantra, timing is everything. The fundamentals have not changed and i am looking forward to 2018 results. So i am still content with being invested here and yes i am showing a loss like most but not concerned at this point :)

All good and moving forward, rpl554 will be a very attractive asset next year on sucessful results.....:)

Lse doesnt seem to report any released RNS for vrp? There must be a fault...

:)

Another postive result :) looking now to the next big set of results...

A retrace is part of the course on aim and gives an opportunity to buy, the fundamentals remain the same and even better with the last set of results. I see there are a number of large buys reported so investors are happy to take a position at this level and wait. The PK results are due this quarter :)

Closed at 16.95, holding steady and looking good....maybe some antcipation to the PK results!

Holding gains in sp and increasing, a very good indicator....:)

16.89 close, very encouraging that we have have held our gain from yesterday and slighty increased today...bodes well for the PK results which could be reported at any time this quarter. It would be opportune if they were to be released early in the quarter rather than later in the quarter :)

16.97 currently...the results will attract investors who have not been previously familiar with 554...the more interest the better, roll on the next set of results this quarter....the copd market is $billions state side so all to play for with 554....if 554 is effective in cf that will be major value adding in its own right :)

£158.00